Full text is available at the source.
Abstract
The Type I-E CRISPR/Cas system in Salmonella enterica may function as a regulatory interface influencing bacterial pathogenesis.
- The system is thought to be integrated into regulatory networks that control pathogenicity islands, biofilm formation, and responses to oxidative stress.
- CRISPR components such as Cascade, Cas3, and Cas6 may deviate from traditional immunity functions, allowing for DNA binding without lethal cleavage.
- This binding is associated with transcriptional modulation via steric hindrance, which could act as a natural interference mechanism.
- Global regulators like H-NS and LeuO may coordinate this system in response to environmental changes, such as fluctuations in pH.
- These findings suggest potential for new therapeutic strategies, including anti-CRISPR therapeutics.
Simplified